4009011139 18916979144 info@yaleedus.com
工作时间:周一至周六 9:00-18:00 , 周日 9:00-15:00
多年7分,今年将首次超8分的SCI,最快1个月接受,发文稳步前进,值得投稿
2021-06-074538

今天,我们来看看这本SCI期刊:EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING。从现有的记录来看,EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 的2020年影响因子(JCR2019)是7.081。

期刊基本信息

关于此刊的具体情况,大家可以看看:

 

来自期刊官网

期刊接受范围

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 的收稿范围,期刊是如此介绍的(截取部分内容),详情请阅读:

 

The European Journal of Nuclear Medicine and Molecular Imaging will remain of primary interest to those practicing the field of imaging, radiopharmaceutical therapy and image guided therapy. The field of interest includes advanced imaging analyses techniques and artificial intelligence application in the field of imaging. Reports on original works related to physics, dosimetry, radiation biology, radiochemistry and pharmacy, will be considered in the field of interest of the EJNMMI. The Journal will welcome original material reflecting the field of molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression and antisense methodologies.

期刊接受时间

对于EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 的接受时间,我们看了几篇新近发表的:只需1-7个月就可以接受!

  • Received: 1 February 2021 /Accepted: 24 March 2021
  • Received: 1 December 2020 / Accepted: 11 February 2021
  • Received: 3 March 2021 /Accepted: 4 April 2021
  • Received: 7 September 2020 /Accepted: 9 March 2021
  • Received: 8 December 2020 /Accepted: 25 March 2021
  • Received: 25 January 2021 /Accepted: 23 March 2021
  • Received: 24 August 2020 /Accepted: 21 March 2021
  • Received: 28 October 2020 /Accepted: 13 March 2021

期刊年发文量

对于EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 的发文量,2017年发文220多篇,2018年发文210多篇,2019年发文301篇,2020年发文350多篇。

影响因子

即时影响因子计算发现,2021年4月13日,8.238分。按照常规期刊计算方法,以及往年经验,在2021年6月份公布的IF中,它或许会首次超8分 !

投稿网址及网页界面

想必大家对如何投稿,也很感兴趣,这里我们简单介绍一下投稿网址及注册过程:以下为注册界面。

 

 

如果还没有注册过账户,只需点击“Register Now”注册账户即可!

有8+分以上发表要求的,来看看这个潜力股的SCI期刊吧!

版权声明:本文为“51选刊”原创,文章转载只为学术传播,不代表本号观点,无商业用途,版权归原作者所有,如涉及侵权问题,请联系我们,我们将及时修改或删除。

学术互动

添加微信获取最新优惠、出版政策、课程直播信息,随时咨询客服/编辑,了解更多实时资讯

热门推荐